首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1378733

2023-2028 年偏頭痛藥物市場報告（依治療類型、藥物類型、給藥途徑、配銷通路和地區）

Migraine Drugs Market Report by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球偏頭痛藥物市場規模達到40億美元。展望未來， IMARC Group預計到2028年市場規模將達到54億美元，2022-2028年複合年成長率（CAGR）為5.1%。

偏頭痛是一種神經系統疾病，會導致前額、頭部側面或眼睛周圍出現單側或搏動性疼痛。疼痛常伴隨自主神經症狀，如噁心、嘔吐、畏光、畏聲等。偏頭痛通常透過檢查患者的病史和症狀、進行血液檢查、磁振造影 (MRI) 和電腦斷層掃描 (CT) 掃描來診斷。目前，非處方藥（OTC）和處方注射劑可緩解症狀並降低偏頭痛發作的頻率和嚴重程度。這些藥物可以定期服用，也可以在慢性疼痛發作或惡化期間服用。

偏頭痛的盛行率和診斷率顯著上升是推動市場成長的關鍵因素之一。除此之外，偏頭痛藥物報銷政策的改善以及精準藥物需求的不斷增加也促進了市場的成長。此外，用於治療偏頭痛的電神經刺激裝置的需求不斷成長，以及處於後期研發階段且具有更高臨床療效的新類別藥物的預期批准，例如降鈣素基因相關勝肽（CGRP）單株抗體的引入，也推動了市場的成長。然而，由於社交距離規範，偏頭痛的臨床就診和程序治療的減少影響了市場的成長。

本報告回答的關鍵問題：

迄今為止，全球偏頭痛藥物市場表現如何，未來幾年將如何表現？
COVID-19 對全球偏頭痛藥物市場有何影響？
主要區域市場有哪些？
根據治療類型的市場分類是怎樣的？
根據藥物類型分類的市場是怎麼樣的？
根據給藥途徑，市場的分化為何？
基於配銷通路的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球偏頭痛藥物市場的結構如何？誰是主要參與者？
產業競爭程度如何？

曲普坦類
- 市場走向
- 市場預測
麥角生物鹼
- 市場走向
- 市場預測
非類固醇抗發炎藥
- 市場走向
- 市場預測
乙醯膽鹼抑制劑/神經毒素
- 市場走向
- 市場預測
迪坦斯
- 市場走向
- 市場預測
CGRP 單株抗體
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 8 章：按管理途徑分類的市場

口服
- 市場走向
- 市場預測
可注射
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 9 章：按配銷通路分類的市場區隔

醫院藥房
- 市場走向
- 市場預測
零售藥局
- 市場走向
- 市場預測
其他
- 市場走向
- 市場預測

第 10 章：按地區分類的市場細分

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Allergan Plc (Abbvie Inc.)
- Amgen Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
- Eisai Co. Ltd.
- Eli Lilly and Company
- Endo International Plc
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Limited

簡介目錄圖表

Product Code: SR112023A2543

Abstract

The global migraine drugs market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2022-2028.

Migraine is a neurological condition that causes unilateral or throbbing pain in the forehead, side of the head or around the eyes. The pain is often accompanied by autonomic symptoms, such as nausea, vomiting, photophobia and phonophobia. Migraine is generally diagnosed by examining the patient's medical history and symptoms, as well as by performing blood tests, and magnetic resonance imaging (MRI) and computerized tomography (CT) scans. At present, over the counter (OTC) medicines and prescribed injections are available to relieve the symptoms and reduce the frequency and severity of migraine attacks. These drugs are either taken regularly or during attacks or exacerbations of chronic pain.

A significant rise in the prevalence and diagnosis of migraine represents one of the key factors bolstering the market growth. Apart from this, the improvement in reimbursement policies for migraine medications, along with the escalating demand for precision medicines, is also contributing to the market growth. Furthermore, the growing demand for electrical nerve stimulating devices to treat migraine and the expected approval of new classes of drugs that are in late-stage pipeline and have higher clinical efficacy, such as the introduction of calcitonin gene-related peptide (CGRP) monoclonal antibodies, are also driving the market growth. However, a decline in clinical visits and procedural treatment of migraines due to social distancing norms has impacted the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global migraine drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment type, drug type, route of administration and distribution channel.

Breakup by Treatment Type:

Abortive Treatment

Preventive Treatment

Breakup by Drug Type:

Triptans

Ergot Alkaloids

NSAIDs

Acetylcholine Inhibitors/ Neurotoxins

Ditans

CGRP mAbs

Others

Breakup by Route of Administration:

Oral

Injectable

Others

Breakup by Distribution Channel:

Hospital-Based Pharmacies

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Allergan Plc (Abbvie Inc.), Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Eisai Co. Ltd., Eli Lilly and Company, Endo International Plc, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Novartis AG, Pfizer Inc., Sanofi SA and Teva Pharmaceutical Industries Limited.

Key Questions Answered in This Report:

How has the global migraine drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global migraine drugs market?
What are the key regional markets?
What is the breakup of the market based on the treatment type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global migraine drugs market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Migraine Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Treatment Type

6.1 Abortive Treatment
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Preventive Treatment
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Triptans
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Ergot Alkaloids
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 NSAIDs
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Acetylcholine Inhibitors/ Neurotoxins
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Ditans
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 CGRP mAbs
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital-Based Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Allergan Plc (Abbvie Inc.)
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 SWOT Analysis
- 15.3.3 Amgen Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 SWOT Analysis
- 15.3.4 AstraZeneca Plc
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Eisai Co. Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Eli Lilly and Company
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Endo International Plc
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 GlaxoSmithKline Plc
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Johnson & Johnson
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Merck & Co.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis
- 15.3.12 Novartis AG
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Pfizer Inc.
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis
- 15.3.14 Sanofi SA
  - 15.3.14.1 Company Overview
  - 15.3.14.2 Product Portfolio
  - 15.3.14.3 Financials
  - 15.3.14.4 SWOT Analysis
- 15.3.15 Teva Pharmaceutical Industries Limited
  - 15.3.15.1 Company Overview
  - 15.3.15.2 Product Portfolio
  - 15.3.15.3 Financials
  - 15.3.15.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Migraine Drugs Market: Major Drivers and Challenges
Figure 2: Global: Migraine Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Migraine Drugs Market: Breakup by Treatment Type (in %), 2022
Figure 4: Global: Migraine Drugs Market: Breakup by Drug Type (in %), 2022
Figure 5: Global: Migraine Drugs Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Migraine Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Migraine Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Migraine Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Migraine Drugs (Abortive Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Migraine Drugs (Abortive Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Migraine Drugs (Preventive Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Migraine Drugs (Preventive Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Migraine Drugs (Triptans) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Migraine Drugs (Triptans) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Migraine Drugs (Ergot Alkaloids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Migraine Drugs (Ergot Alkaloids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Migraine Drugs (NSAIDs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Migraine Drugs (NSAIDs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Migraine Drugs (Acetylcholine Inhibitors/ Neurotoxins) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Migraine Drugs (Acetylcholine Inhibitors/ Neurotoxins) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Migraine Drugs (Ditans) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Migraine Drugs (Ditans) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Migraine Drugs (CGRP mAbs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Migraine Drugs (CGRP mAbs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Migraine Drugs (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Migraine Drugs (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Migraine Drugs (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Migraine Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Migraine Drugs (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Migraine Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Migraine Drugs (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Migraine Drugs (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Migraine Drugs (Hospital-Based Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Migraine Drugs (Hospital-Based Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Migraine Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Migraine Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Migraine Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Migraine Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: North America: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: North America: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: United States: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: United States: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Canada: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Canada: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Asia Pacific: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Asia Pacific: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: China: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: China: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Japan: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Japan: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: India: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: India: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: South Korea: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: South Korea: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Australia: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Australia: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Indonesia: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Indonesia: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Europe: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Europe: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Germany: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Germany: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: France: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: France: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: United Kingdom: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: United Kingdom: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Italy: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Italy: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Spain: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Spain: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Russia: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Russia: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Latin America: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Latin America: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Brazil: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Brazil: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Mexico: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Mexico: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Middle East and Africa: Migraine Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Middle East and Africa: Migraine Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Migraine Drugs Industry: SWOT Analysis
Figure 88: Global: Migraine Drugs Industry: Value Chain Analysis
Figure 89: Global: Migraine Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Migraine Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Migraine Drugs Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 3: Global: Migraine Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
Table 4: Global: Migraine Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 5: Global: Migraine Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Migraine Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Migraine Drugs Market Structure
Table 8: Global: Migraine Drugs Market: Key Players

02-2729-4219

+886-2-2729-4219